Roger McIntyre, MD

Roger McIntyre, MD, is a professor of psychiatry and pharmacology at the University of Toronto and head of the Mood Disorders Psychopharmacology Unit at the University Health Network, in Toronto, Canada. Dr McIntyre is also the executive director of the Brain and Cognition Discovery Foundation in Toronto. In 2014, Thomson Reuters named Dr McIntyre one of “The World’s Most Influential Scientific Minds.” This distinction is given by publishing the largest number of articles that rank among those most frequently cited by researchers globally in 21 broad fields of science and social science during the previous decade.

Dr McIntyre is involved in multiple research endeavors. His works broadly aims to characterize the underlying causes of cognitive impairment in individuals with mood disorders and their impact on workplace functioning. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment. Dr McIntyre is the co-chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force on the Treatment of Comorbidity in Adults With Major Depressive Disorder or Bipolar Disorder and a contributor to the CANMAT guidelines for the treatment of depressive disorders and bipolar disorders. Dr McIntyre has published hundreds of peer-reviewed articles and has edited and/or co-edited several textbooks on mood disorders.